Identifying the optimal deep learning architecture and parameters for automatic beam aperture definition in 3D radiotherapy.


Journal

Journal of applied clinical medical physics
ISSN: 1526-9914
Titre abrégé: J Appl Clin Med Phys
Pays: United States
ID NLM: 101089176

Informations de publication

Date de publication:
Dec 2023
Historique:
revised: 08 07 2023
received: 16 04 2023
accepted: 07 08 2023
medline: 4 12 2023
pubmed: 6 9 2023
entrez: 6 9 2023
Statut: ppublish

Résumé

Two-dimensional radiotherapy is often used to treat cervical cancer in low- and middle-income countries, but treatment planning can be challenging and time-consuming. Neural networks offer the potential to greatly decrease planning time through automation, but the impact of the wide range of hyperparameters to be set during training on model accuracy has not been exhaustively investigated. In the current study, we evaluated the effect of several convolutional neural network architectures and hyperparameters on 2D radiotherapy treatment field delineation. Six commonly used deep learning architectures were trained to delineate four-field box apertures on digitally reconstructed radiographs for cervical cancer radiotherapy. A comprehensive search of optimal hyperparameters for all models was conducted by varying the initial learning rate, image normalization methods, and (when appropriate) convolutional kernel size, the number of learnable parameters via network depth and the number of feature maps per convolution, and nonlinear activation functions. This yielded over 1700 unique models, which were all trained until performance converged and then tested on a separate dataset. Of all hyperparameters, the choice of initial learning rate was most consistently significant for improved performance on the test set, with all top-performing models using learning rates of 0.0001. The optimal image normalization was not consistent across architectures. High overlap (mean Dice similarity coefficient = 0.98) and surface distance agreement (mean surface distance < 2 mm) were achieved between the treatment field apertures for all architectures using the identified best hyperparameters. Overlap Dice similarity coefficient (DSC) and distance metrics (mean surface distance and Hausdorff distance) indicated that DeepLabv3+ and D-LinkNet architectures were least sensitive to initial hyperparameter selection. DeepLabv3+ and D-LinkNet are most robust to initial hyperparameter selection. Learning rate, nonlinear activation function, and kernel size are also important hyperparameters for improving performance.

Identifiants

pubmed: 37670488
doi: 10.1002/acm2.14131
pmc: PMC10691634
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e14131

Informations de copyright

© 2023 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, LLC on behalf of The American Association of Physicists in Medicine.

Références

Med Phys. 2020 Nov;47(11):5592-5608
pubmed: 33459402
Pract Radiat Oncol. 2020 Sep - Oct;10(5):e415-e424
pubmed: 32450365
Int J Radiat Oncol Biol Phys. 2018 Jun 1;101(2):468-478
pubmed: 29559291
J Appl Clin Med Phys. 2023 Dec;24(12):e14131
pubmed: 37670488
Oncol Lett. 2020 Sep;20(3):2058-2074
pubmed: 32782524
IEEE Trans Med Imaging. 2023 Apr;42(4):1172-1184
pubmed: 36427285
Semin Radiat Oncol. 2020 Oct;30(4):340-347
pubmed: 32828389
Comput Methods Programs Biomed. 2019 Aug;177:285-296
pubmed: 31319957
Phys Med Biol. 2018 Nov 07;63(21):215026
pubmed: 30403188
Radiother Oncol. 2017 Jan;122(1):66-71
pubmed: 27939201
IEEE Trans Pattern Anal Mach Intell. 2018 Apr;40(4):834-848
pubmed: 28463186
J Glob Oncol. 2019 Jan;5:1-9
pubmed: 30629457
Gynecol Oncol Rep. 2018 Jan 05;24:30-35
pubmed: 29892691
BMC Med Imaging. 2020 Oct 15;20(1):116
pubmed: 33059612
Int J Radiat Oncol Biol Phys. 2014 Jul 1;89(3):448-57
pubmed: 24751411
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
J Glob Oncol. 2016 May 25;2(5):311-340
pubmed: 28717717
J Vis Exp. 2018 Apr 11;(134):
pubmed: 29708544
Int J Radiat Oncol Biol Phys. 1995 Dec 1;33(5):1053-60
pubmed: 7493831
Pract Radiat Oncol. 2013 Oct-Dec;3(4):e139-47
pubmed: 24674411
Front Med (Lausanne). 2022 Jan 03;8:755309
pubmed: 35047520
J Appl Clin Med Phys. 2021 Sep;22(9):94-102
pubmed: 34250715
Semin Radiat Oncol. 2019 Jul;29(3):185-197
pubmed: 31027636
J Clin Oncol. 2003 Feb 1;21(3):555-63
pubmed: 12560449
J Glob Oncol. 2018 Jul;4:1-11
pubmed: 30110221

Auteurs

Skylar S Gay (SS)

Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Kelly D Kisling (KD)

University of California San Diego, San Diego, California, USA.

Brian M Anderson (BM)

University of California San Diego, San Diego, California, USA.

Lifei Zhang (L)

Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Dong Joo Rhee (DJ)

Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Callistus Nguyen (C)

Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Tucker Netherton (T)

Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Jinzhong Yang (J)

Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Kristy Brock (K)

Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Anuja Jhingran (A)

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Hannah Simonds (H)

University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom.

Ann Klopp (A)

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Beth M Beadle (BM)

Department of Radiation Oncology, Stanford University, Palo Alto, California, USA.

Laurence E Court (LE)

Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Carlos E Cardenas (CE)

Department of Radiation Oncology, The University of Alabama at Birmingham, Birmingham, Alabama, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH